Jordan E Lake

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Participation of women in HIV clinical trials: the IPEC-FIOCRUZ experience
    Jordan E Lake
    Division of Infectious Diseases, University of California at Los Angeles, Los Angeles, CA, USA
    HIV AIDS (Auckl) 3:61-8. 2011
  2. pmc A pilot study of telmisartan for visceral adiposity in HIV infection: the metabolic abnormalities, telmisartan, and HIV infection (MATH) trial
    Jordan E Lake
    Division of Infectious Diseases, Department of Medicine, University of California Los Angeles, Los Angeles, California, USA
    PLoS ONE 8:e58135. 2013
  3. pmc A randomized trial of Raltegravir replacement for protease inhibitor or non-nucleoside reverse transcriptase inhibitor in HIV-infected women with lipohypertrophy
    Jordan E Lake
    Department of Medicine, University of California, Los Angeles, Los Angeles, California 90035, USA
    AIDS Patient Care STDS 26:532-40. 2012
  4. pmc Vitamin D in HIV-Infected Patients
    Jordan E Lake
    Center for Clinical AIDS Research and Education, David Geffen School of Medicine at UCLA, USA
    Curr HIV/AIDS Rep 8:133-41. 2011
  5. pmc Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997-2011
    David A Martin
    University of California, Los Angeles, Los Angeles, USA
    BMC Infect Dis 14:322. 2014
  6. doi Metabolic disease in HIV infection
    Jordan E Lake
    David Geffen School of Medicine, University of California, Los Angeles, CA, USA
    Lancet Infect Dis 13:964-75. 2013
  7. pmc A novel combination HIV prevention strategy: post-exposure prophylaxis with contingency management for substance abuse treatment among methamphetamine-using men who have sex with men
    Raphael J Landovitz
    UCLA Center for Clinical AIDS Research and Education, David Geffen School of Medicine, University of California, Los Angeles, USA
    AIDS Patient Care STDS 26:320-8. 2012
  8. ncbi Bringing testing to the people - benefits of mobile unit HIV/syphilis testing in Lima, Peru, 2007-2009
    Mindy C Lipsitz
    South American Program in HIV Prevention Research SAPHIR, University of California at Los Angeles David Geffen School of Medicine, Los Angeles, CA, USA
    Int J STD AIDS 25:325-31. 2014
  9. pmc Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study
    Jordan E Lake
    Division of Infectious Diseases, CARE Center, UCLA, Los Angeles, CA, USA
    AIDS Care 23:929-38. 2011

Collaborators

Detail Information

Publications9

  1. pmc Participation of women in HIV clinical trials: the IPEC-FIOCRUZ experience
    Jordan E Lake
    Division of Infectious Diseases, University of California at Los Angeles, Los Angeles, CA, USA
    HIV AIDS (Auckl) 3:61-8. 2011
    ..This analysis describes the characteristics of women in the cohort who participated in HIV clinical trials between 1999 and 2008...
  2. pmc A pilot study of telmisartan for visceral adiposity in HIV infection: the metabolic abnormalities, telmisartan, and HIV infection (MATH) trial
    Jordan E Lake
    Division of Infectious Diseases, Department of Medicine, University of California Los Angeles, Los Angeles, California, USA
    PLoS ONE 8:e58135. 2013
    ..Telmisartan, an angiotensin receptor blocker and partial PPAR-γ agonist, has been shown to decrease visceral fat and improve metabolic and inflammatory parameters in HIV-uninfected subjects...
  3. pmc A randomized trial of Raltegravir replacement for protease inhibitor or non-nucleoside reverse transcriptase inhibitor in HIV-infected women with lipohypertrophy
    Jordan E Lake
    Department of Medicine, University of California, Los Angeles, Los Angeles, California 90035, USA
    AIDS Patient Care STDS 26:532-40. 2012
    ..Additional insights into AT and metabolic changes in women on RAL will be provided by 48-week follow-up of the immediate-switch arm...
  4. pmc Vitamin D in HIV-Infected Patients
    Jordan E Lake
    Center for Clinical AIDS Research and Education, David Geffen School of Medicine at UCLA, USA
    Curr HIV/AIDS Rep 8:133-41. 2011
    ..This paper reviews data published on HIV infection and vitamin D health in adults over the last year...
  5. pmc Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997-2011
    David A Martin
    University of California, Los Angeles, Los Angeles, USA
    BMC Infect Dis 14:322. 2014
    ..We aimed to examine the factors associated with virologic suppression for HIV-infected patients on ART receiving care at the Evandro Chagas Clinical Research Institute, Oswaldo Cruz Foundation in Rio de Janeiro, Brazil...
  6. doi Metabolic disease in HIV infection
    Jordan E Lake
    David Geffen School of Medicine, University of California, Los Angeles, CA, USA
    Lancet Infect Dis 13:964-75. 2013
    ....
  7. pmc A novel combination HIV prevention strategy: post-exposure prophylaxis with contingency management for substance abuse treatment among methamphetamine-using men who have sex with men
    Raphael J Landovitz
    UCLA Center for Clinical AIDS Research and Education, David Geffen School of Medicine, University of California, Los Angeles, USA
    AIDS Patient Care STDS 26:320-8. 2012
    ..Findings demonstrate that PEP, when combined with CM, is safe, feasible, and acceptable as an HIV prevention strategy in methamphetamine-using MSM...
  8. ncbi Bringing testing to the people - benefits of mobile unit HIV/syphilis testing in Lima, Peru, 2007-2009
    Mindy C Lipsitz
    South American Program in HIV Prevention Research SAPHIR, University of California at Los Angeles David Geffen School of Medicine, Los Angeles, CA, USA
    Int J STD AIDS 25:325-31. 2014
    ..Investigation into whether MU attendees would otherwise access HIV testing is warranted to determine the impact of MU testing...
  9. pmc Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study
    Jordan E Lake
    Division of Infectious Diseases, CARE Center, UCLA, Los Angeles, CA, USA
    AIDS Care 23:929-38. 2011
    ..Peripheral lipoatrophy (as measured by leg SAT) is associated with striking increased CVD risk in HIV-infected patients even after controlling for VAT, whereas low leg SAT is associated with low CVD risk in controls...